Establishment of prophylaxis/therapies based on clarification of all types of pneumonia and underlying diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1090220360

Enrollment

2000

Registered

2018-07-03

Start date

2018-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pneumonia

Interventions

Intervention type: Name of intervention: Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application: Dose per administration: Dosing frequency / Frequency of use:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Diagnosed as Pneumonia by chest X-ray, the following symptoms are observed: pyrexia, cough, dyspnea, chest pain, general malaise and/or sputum 2) Age: More than 15 years old. 3) Under hospital care

Exclusion criteria

Exclusion criteria: Patients with an infiltrate other tha pneumonia, (i.e., acute congestive heart failure, pulmonary infarction or interstitial pneumonia)

Design outcomes

Primary

Measure	Time frame
1) Capsular serotype of clinically isolated S.pneumoniae 2) Minimum inhibitory concentration (MIC) of these isolates 3) Capsular serotype of non-invasive pneumococcal pneumonia with UAD 4) Risk factors of drug resistance, severity, sequelae and mortality	—

Countries

Japan

Contacts

Public ContactTakaya Maruyama

National Hospital Organization Mie National Hospital

maruyamat@mie-m.hosp.go.jp+81-59-232-2531

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026